Amaran was created by Obi Pharma which is in phase 2-3 with it OBI-822 against breast cancer (should also work with other cancer,e.i prostate). Obi-822 is actually made with Globo-H (acquired from Sloan) and KLH. That's why Obi pharma used Amaran to secure KLH supply with Stellar by the aqcuisition of 10% of its equity and by naming a member on its board who has experience in drug development against CDiff !
Some data on phase 2 in the US is likely this december and phase 3 will be completed in Taiwan by feburary were a third of the participants are treated since 2010
Bloomberg
Amaran Biotechnology Inc. Key Developments
Amaran Biotechnology Inc. to Invest USD 33.41 Million in Taiwanese Factory for Botox Biosimilar
Jul 31 13
Amaran Biotechnology Inc. has announced plans to invest TWD 1 billion in a factory and research centre in Taiwan's Hsinchu Biomedical Science Park, Taipei, in relation to conducting clinical trials and manufacturing drugs developed by OBI Pharma Inc, a subsidiary of Optimer Pharmaceuticals. The new factory will initially focus on production of a biosimilar of botulinum toxin type A, otherwise known as Botox, for use in cosmetic surgery, along with other generic protein drugs, Amaran states. Amaran stated that the factory will have the capacity to produce OBI's flagship R&D hope, OBI-822, a first-in-class immunotherapy for metastatic breast cancer currently at the Phase II/III stage.
News 
Market Data 
Discover 
